These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3112014)

  • 61. Genetic control of resistance to Mycobacterium intracellulare infection in mice.
    Goto Y; Nakamura RM; Takahashi H; Tokunaga T
    Infect Immun; 1984 Oct; 46(1):135-40. PubMed ID: 6480104
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of delayed hypersensitivity in the enhancement of host resistance to infection.
    Hsu HS; Miller KB; Nakoneczna I
    Can J Microbiol; 1980 Dec; 26(12):1438-42. PubMed ID: 7016277
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: establishment of latency and reactivation.
    Brown DH; Miles BA; Zwilling BS
    Infect Immun; 1995 Jun; 63(6):2243-7. PubMed ID: 7768604
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice.
    Huygen K; Abramowicz D; Vandenbussche P; Jacobs F; De Bruyn J; Kentos A; Drowart A; Van Vooren JP; Goldman M
    Infect Immun; 1992 Jul; 60(7):2880-6. PubMed ID: 1612754
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Control of the Bcg gene of early resistance in mice to infections with BCG substrains and atypical mycobacteria.
    Denis M; Forget A; Pelletier M; Turcotte R; Skamene E
    Clin Exp Immunol; 1986 Mar; 63(3):517-25. PubMed ID: 3086001
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intrapulmonary BCG cell wall vaccination in mice.
    Reuman PD; Ayoub EM
    Microbios; 1987; 49(198):7-15. PubMed ID: 3550393
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of Mycobacterium bovis BCG vaccination on interleukin-1 beta and RANTES mRNA expression in guinea pig cells exposed to attenuated and virulent mycobacteria.
    Jeevan A; Yoshimura T; Foster G; McMurray DN
    Infect Immun; 2002 Mar; 70(3):1245-53. PubMed ID: 11854207
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Continuous expression of I-A antigen by peritoneal macrophages from mice resistant to Mycobacterium bovis (strain BCG).
    Johnson SC; Zwilling BS
    J Leukoc Biol; 1985 Nov; 38(5):635-47. PubMed ID: 3930641
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Passive transfer of immunity of Mycobacterium avium in susceptible and resistant strains of mice.
    Stokes RW; Collins FM
    Clin Exp Immunol; 1990 Jul; 81(1):109-15. PubMed ID: 2116245
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A genetic map of mouse chromosome 1 near the Lsh-Ity-Bcg disease resistance locus.
    Mock B; Krall M; Blackwell J; O'Brien A; Schurr E; Gros P; Skamene E; Potter M
    Genomics; 1990 May; 7(1):57-64. PubMed ID: 1970800
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis.
    Kramnik I; Dietrich WF; Demant P; Bloom BR
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8560-5. PubMed ID: 10890913
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aerogenic vaccination of mice with Mycobacterium bovis BCG.
    Orme IM; Collins FM
    Tubercle; 1986 Jun; 67(2):133-40. PubMed ID: 3775862
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene.
    Goto Y; Buschman E; Skamene E
    Immunogenetics; 1989; 30(3):218-21. PubMed ID: 2673999
    [No Abstract]   [Full Text] [Related]  

  • 78. Tuberculin shock in red mice and CF1 mice immunized with strains of BCG or Mycobacterium tuberculosis.
    Jespersen A
    Acta Pathol Microbiol Scand B; 1976 Oct; 84B(5):273-79. PubMed ID: 823795
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Study of DTH and resistance in Mycobacterium lepraemurium infection using a T-cell line isolated from mice infected with Mycobacterium bovis (BCG).
    Hussein S; Curtis J; Griffiths D; Turk JL
    Cell Immunol; 1987 Apr; 105(2):423-31. PubMed ID: 3032464
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.
    Marcus SA; Steinberg H; Talaat AM
    Vaccine; 2015 Oct; 33(42):5633-5639. PubMed ID: 26363381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.